Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing
Identification of genetic alterations is important for family risk assessment in colorectal cancers. Next-generation sequencing (NGS) technologies provide useful tools for single-nucleotide and copy number variation (CNV) identification in many genes and samples simultaneously. Herein, we present the validation of current Multiplicom MASTR designs of mismatch repair combined to familial adenomatous polyposis genes in a single PCR reamplification test for eight DNA samples simultaneously on a MiSeq apparatus.
Source: Journal of Molecular Diagnostics - Category: Pathology Authors: Jean-Marc Rey, Vincent Ducros, Pascal Pujol, Qing Wang, Marie-Pierre Buisine, Hanaa Aissaoui, Thierry Maudelonde, Sylviane Olschwang Tags: Regular Article Source Type: research
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Gastroschisis Repair | Genetics | Pathology